» Authors » Karol Bigosinski

Karol Bigosinski

Explore the profile of Karol Bigosinski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 3
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitura-Lesiuk M, Dubaj M, Dembowska A, Bigosinski K, Raniewicz M
J Clin Med . 2024 Sep; 13(17). PMID: 39274398
: Hyperleukocytosis, defined as a total leukocyte count of more than 50,000/mm leukocytes, occurs in almost one in five children with acute lymphoblastic leukemia (ALL). It represents an unfavorable prognostic...
2.
Dubaj M, Bigosinski K, Szudy-Szczyrek A, Szumilo J, Hus M
Pol Arch Intern Med . 2024 Aug; 134(11). PMID: 39167042
No abstract available.
3.
Suszek D, Dubaj M, Bigosinski K, Dembowska A, Kaniewski M, Sielwanowska W, et al.
Reumatologia . 2024 Jul; 62(3):187-195. PMID: 39055730
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by high heterogeneity of clinical manifestations and an uncertain prognosis. Although the mortality rate due to SLE has decreased significantly in...
4.
Dubaj M, Dembowska A, Bigosinski K, Belniak E, Rejdak K
Postep Psychiatr Neurol . 2024 Jul; 33(1):39-42. PMID: 38948686
Purpose: Multiple sclerosis (MS) and systemic lupus erythematosus (SLE) are two autoimmune diseases that are relatively common, especially in women. However, it is extremely rare for them to coexist in...
5.
Dubaj M, Bigosinski K, Dembowska A, Mlak R, Szudy-Szczyrek A, Malecka-Massalska T, et al.
Cancers (Basel) . 2024 Mar; 16(5). PMID: 38473390
Multiple myeloma (MM) is the second most common hematologic malignancy in the world and accounts for 15% of primary hemocytopathies, with an ever-increasing number of new cases. It is asymptomatic...